| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8316728 | Clinica Chimica Acta | 2011 | 6 Pages |
Abstract
NT-proBNP levels, as a screening tool for cardiac structural/functional disease, appear to be limited, because of the low specificity. However, the strong association between its concentration and the establishment of irreversible cardiac hypertrophy prompts successive studies aimed to ascertain the use of its serum levels as an early alert indicator of disease severity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Enrico Di Stasio, Andrea Russo, Marco Mettimano, Domenico Viviani, Alessandro Scagliusi, Antonio Bruno, Alessandro Giuliani, Maria Antonietta Isgrò, Federica Romitelli, Luigi Savi,